Collector
In Fight Against Pancreatic Cancer, Daraxonrasib Is Rare Sign Of Hope | Collector
In Fight Against Pancreatic Cancer, Daraxonrasib Is Rare Sign Of Hope
Forbes Tech

In Fight Against Pancreatic Cancer, Daraxonrasib Is Rare Sign Of Hope

The death rate in the group treated with daraxonrasib was 60% lower than those on chemotherapy. This is hailed as a major advance against metastatic pancreatic cancer.

Go to News Site